Bronchoscopic microwave ablation safe for inoperable lung malignancies Jacinthlyn Sylvia14 April 2023 11:15 AM ISTUK: A new study conducted by K. Lau and the team suggests that bronchoscopic microwave ablation (BMA) is an alternate therapy for people with...
USFDA accepts Pfizer supplemental new drug applications for BRAFTOVI plus MEKTOVI Ruchika Sharma5 April 2023 12:00 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug...
Cancer patients have increased risk of STEMI-associated mortality Jacinthlyn Sylvia29 March 2023 8:00 PM ISTCancer, especially lung cancer, increases the risk of short- and long-term death in ST elevation myocardial infarction (STEMI) patients, says an...
Medical Bulletin 27/March/2023 Dr. Nandita Mohan27 March 2023 5:15 PM ISTHere are the top medical news for the day:Study shows Buprenorphine after nonfatal opioid overdose reduces risk of overdose deathReceiving...
Saving more lung tissue in lung cancer surgeries supported in new study Isra Zaman27 March 2023 9:15 AM ISTThe traditional treatment for early-stage non-small cell lung cancer is a lobectomy, where a surgeon eradicates cancerous tissue by removing an entire...
Before surgery immunotherapy plus chemotherapy improves patient outcomes in operable lung cancer: Study Isra Zaman21 March 2023 9:30 AM ISTAmong patients diagnosed with NSCLC, roughly 30% have potentially resectable disease, meaning their tumor can be surgically removed. While many of...
Medical Bulletin 21/March/2023 Isra Zaman21 March 2023 3:15 AM ISTHere are the top medical news for the day:Before surgery immunotherapy plus chemotherapy improves patient outcomes in operable lung cancer: StudyAmong...
USFDA approves Alembic Pharma anti-cancer injection Docetaxel Ruchika Sharma1 March 2023 3:12 PM ISTDocetaxel Injections are indicated for the breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric adenocarcinoma and...
Merck scraps another prostate cancer study as Keytruda therapy disappoints Ruchika Sharma1 March 2023 2:15 PM ISTNew Delhi: Merck & Co said on Tuesday it will stop a late-stage trial evaluating a combination therapy with its cancer drug Keytruda after interim...
Imfinzi plus Imjudo approved in EU for patients with advanced liver and non small cell lung cancers: AstraZeneca Ruchika Sharma25 Feb 2023 10:00 AM ISTUK: AstraZeneca has announced that Imfinzi (durvalumab) and Imjudo (tremelimumab) immunotherapy combinations have been approved in the European Union...
Why lung cancer doesn't respond well to immunotherapy Dr. Kamal Kant Kohli18 Feb 2023 9:30 AM ISTImmunotherapy-drug treatment that stimulates the immune system to attack tumors-works well against some types of cancer, but it has shown mixed...
Medical Bulletin 16/February/2023 Isra Zaman16 Feb 2023 3:38 PM ISTHere are the top medical news for the day:Study finds neoadjuvant nivolumab to show long-term benefit in patients with non-small cell lung...
